Susquehanna International Group, LLP Syros Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2021 Aug 11, 2021	SELL	$5.01 - $7.48 $70,140 - $104,720	-14,000 Reduced 28.51%	35,100 $191,000
Q1 2021 May 17, 2021	SELL	$7.19 - $14.95 $249,493 - $518,765	-34,700 Reduced 41.41%	49,100 $367,000
Q4 2020 Feb 16, 2021	BUY	$6.66 - $14.66 $323,010 - $711,010	48,500 Added 137.39%	83,800 $909,000
Q4 2019 Feb 14, 2020	SELL	$4.52 - $10.1 $68,252 - $152,510	-15,100 Reduced 29.96%	35,300 $244,000
Q3 2019 Nov 14, 2019	BUY	$7.14 - $11.65 $192,780 - $314,550	27,000 Added 115.38%	50,400 $523,000
Q3 2018 Nov 14, 2018	BUY	$9.74 - $12.92 $116,880 - $155,040	12,000 Added 105.26%	23,400 $279,000
Q2 2018 Aug 14, 2018	SELL	$10.16 - $13.65 $75,184 - $101,010	-7,400 Reduced 39.36%	11,400 $116,000
Q1 2018 May 15, 2018	BUY	$9.47 - $12.98 $178,036 - $244,024	18,800 New	18,800 $244,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $4.86M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.